Companies: 10,795·Total market cap: $144.5T
Core Laboratories N.V.

Core Laboratories N.V.

CLBNYSEEnergy● Active
$13.43
+$0.50(+3.87%)
Market Cap$619078439
P/E Ratio
52W High$20.36
52W Low$9.72
Overview

Core Laboratories N.V. (CLB) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

clb · stock forecast · 37 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 37 Wall Street analysts in the past 3 months

SellBuy

Hold

37 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
16
Hold
17
Sell
4
Strong Sell
0
Total: 37 · Buy rate: 43.2%

12-Month Price Target

High

$32.00

Consensus

$25.00

+86.2% upside

Low

$17.00

Median: $26 · Last Close: $13.43

The Core Laboratories N.V. (CLB) analyst consensus is Hold, based on ratings from 37 Wall Street analysts over the past 3 months. The average 12-month CLB price target is $25.00, representing +86.2% upside from the current price of $13.43.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $25 (86.2%)

Consensus Target

$25.00

86.2% upside

High Target

$32

138.3%

Low Target

$17

26.6%

Current Price

$13.43

as of today

Based on analyst price targets, the CLB stock price prediction for the next 12 months ranges from $17 to $32. The consensus CLB price forecast of $25.00 implies 86.2% upside from the current price of $13.43.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$13.221.58%

1-day model range: $13.09–$13.34. Peak: $13.34 (-1.58%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$9-30.6%
2028$8-42.2%
2029$7-47.6%
2030$7-50.3%
2031-51.6%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)48.6Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CLB · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$13.40BUY
MA 10$13.70SELL
MA 20$13.65SELL
MA 50$15.13SELL
MA 100$16.50SELL
MA 200$15.44SELL
Current $CLB · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$13.42BUY
EMA 10$13.57SELL
EMA 20$13.86SELL
EMA 50$14.78SELL
EMA 100$15.43SELL
EMA 200$15.47SELL
Current $CLB · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Stifel2025-07-16
Maintains
HoldHold
Citigroup2025-05-13
Maintains
NeutralNeutral
Stifel2025-04-15
Maintains
HoldHold
Citigroup2025-03-12
Upgrade ↑
SellNeutral
Citigroup2025-02-20
Maintains
SellSell
Citigroup2024-10-31
Maintains
SellSell
Piper Sandler2023-05-01
Maintains
NeutralNeutral
Stifel2023-04-28
Maintains
HoldHold
B of A Securities2023-04-18
Downgrade ↓
NeutralUnderperform
Citigroup2023-02-07
Maintains
NeutralNeutral

Wall Street analysts have recently issued updated ratings on Core Laboratories N.V. (CLB) stock. Of the recent 127 rating actions, 23 were upgrades and 22 were downgrades. 37 analysts currently cover CLB.

Analyst Recommendation Trends

Buy ratings00
Hold ratings01↑ +1
Sell ratings101

CLB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$527M

↑ 1.7% YoY

Revenue Next Year

$520M

↓ 1.2% YoY

EPS This Year

$0.88

EPS Next Year

$0.74

↓ 16.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CLB EPS of $0.88 for the current fiscal year, based on estimates from 3 analysts. The CLB revenue forecast is $527M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CLB stock forecast is supported by two independent data sources: analyst consensus ratings from 37 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CLB price target is $25.00 (+86.2% upside), with an analyst consensus of Hold.

The CLB short-term stock prediction for tomorrow is $13.22 (-1.58%). The CLB stock price prediction for 2027 estimates an average of $9. The CLB stock prediction for 2030 projects a range of $6–$7.

Core Laboratories N.V. trades on NYSE under the ticker CLB. The CLB stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 43% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CLB forecast · 8 questions

According to 37 Wall Street analysts, the average 12-month CLB price target is $25.00, with a high forecast of $32.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +86.2% potential upside from the current price of $13.43.

CLB price targetWhat is CLB price targetCLB analyst price targetCLB 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.